NCT00752037View on ClinicalTrials.gov

Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

April 30, 2010

Study Completion Date

June 30, 2010

Conditions
HIV Infections
Interventions
DRUG

lopinavir/ritonavir and raltegravir

lopinavir/ritonavir 400/100 mg po b.id. in combination with raltegravir 400 mg po b.i.d.

Trial Locations (1)

07102

Saint Michael's Medical Center, Newark

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Saint Michael's Medical Center

OTHER